Intuitive Surgical Q2 2026: Revenue +19%, EPS $2.29, Da Vinci Procedures +15%
ISRG is trading near its 52-week low of $342.1 (2.8% above the low).
Summary
Intuitive Surgical posted Q2 2026 revenue of $2.89 billion (+19% YoY) and diluted EPS of $2.29, with da Vinci procedures up 15%. The company repurchased $1.5 billion in stock during H1 and holds $8.6 billion in cash.
Key Events · Earnings and Guidance · ISRG
-
Q2 Revenue +19% to $2.89B
Driven by an 18% increase in instruments and accessories and a 19% jump in systems revenue, total revenue rose 19% year-over-year to $2.89 billion.
-
Da Vinci Procedures +15%, Ion +36%
Approximately 889,000 da Vinci procedures were performed, up 15%, with U.S. growth of 12% and OUS growth of 20%. Ion procedures surged 36% to roughly 47,900.
-
468 Da Vinci Systems Placed
System placements increased 18% to 468 units, including 246 da Vinci 5 systems. The installed base reached about 11,710 systems, up 12% year-over-year.
-
Gross Margin Expands to 67.8%
Gross profit margin improved to 67.8% from 66.3% a year ago, helped by IEEPA tariff refunds, lower logistics costs, and fixed overhead leverage.
Analysis · ISRG · Industrial Applications And Services
A standout quarter for Intuitive Surgical saw revenue climb 19% to $2.89 billion and diluted EPS reach $2.29, comfortably ahead of expectations. Procedure growth remained a pillar of strength: da Vinci volumes rose 15%, fueled by general surgery and gynecology in the U.S. and broad-based momentum overseas. The company placed 468 da Vinci systems—including 246 next-generation da Vinci 5 units—while gross margins expanded to 67.8%. Operating income surged 31% to $972 million. The balance sheet stays fortress-like with $8.6 billion in cash and investments, even after $1.5 billion in share repurchases during the first half. The March close of the Southern European direct-distribution acquisition added $533 million in assets. Multiple insiders adopted 10b5-1 plans, though the amounts are modest relative to the company's size. With the stock trading near its 52-week low, the strong results and aggressive buybacks could serve as a catalyst for a re-rating.
How filings like this one have moved
In the 30 days to Oct 4, 2026, 41.1% of the 304 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.53%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ISRG was trading at $351.59 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $124B. The 52-week trading range was $342.10 to $603.88. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.